Outbreak of multidrug-resistant Acinetobacter boumannii in a Belgian university hospital after transfer of patients from Greece

被引:35
作者
Wybo, I. [3 ]
Blommaert, L. [3 ]
De Beer, T. [3 ]
Soetens, O. [3 ]
De Regt, J. [1 ]
Lacor, P. [2 ]
Pierard, D. [3 ]
Lauwers, S. [3 ]
机构
[1] Univ Ziekenhuis Brussel, Dept Intens Care, B-1090 Brussels, Belgium
[2] Univ Ziekenhuis Brussel, Dept Internal Med, B-1090 Brussels, Belgium
[3] Univ Ziekenhuis Brussel, Dept Microbiol & Hosp Infect Control, B-1090 Brussels, Belgium
关键词
outbreak; Acinetobacter baumannii; infection control; multidrug resistance; OXA-58; beta-lactamases;
D O I
10.1016/j.jhin.2007.09.012
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Multidrug-resistant (MDR) Acinetobacter baumannii are emerging as important nosocomial pathogens. These organisms have a capacity for long-term survival, in the hospital environment. The purpose of this study was to describe the course and control of an outbreak with MDR A. baumannii in a Belgian university hospital after transfer of two trauma patients from Greece. Wounds in both patients were colonised with MDR A. baumannii. Over an 11 month period from September 2004 to July 2005, carbapenem-non-susceptible A. baumannii (producing carbapenem-hydrolysing oxacillinase OXA-58) were isolated from 28 patients, despite early implementation of contact precautions. MDR A. baumannii was detected in routine clinical diagnostic samples from 26 patients and in screening specimens from an additional two patients. Twenty patients (71.4%) were colonised or infected during their stay in intensive care. Twenty-four (85.7%) respiratory samples were positive for MDR A. baumannii. Careful review of all procedures related to the respiratory tract did not identify a common route of transmission. Outbreak control, required multiple interventions, including contact isolation of colonised and infected patients, monitoring the practice of personnel, screening of asymptomatic patients, use of isolation rooms and enhanced environmental disinfection. Introduction of single-use ventilator circuits was considered but the outbreak was controlled before implementation. (c) 2007 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:374 / 380
页数:7
相关论文
共 19 条
[1]  
[Anonymous], MANUAL CLIN MICROBIO
[2]   Acinetobacter spp, as nosocomial pathogens: Microbiological, clinical, and epidemiological features [J].
BergogneBerezin, E ;
Towner, KJ .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (02) :148-+
[3]   First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy [J].
Bertini, Alessia ;
Giordano, Alessandra ;
Varesi, Paola ;
Villa, Laura ;
Mancini, Carlo ;
Carattoli, Alessandra .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (06) :2268-2269
[4]   Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium [J].
Bogaerts, Pierre ;
Naas, Thierry ;
Wybo, Ingrid ;
Bauraing, Caroline ;
Soetens, Oriane ;
Pierard, Denis ;
Nordmann, Patrice ;
Glupczynski, Youri .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (11) :4189-4192
[5]   Multiresistant acinetobacter in the UK: how big a threat? [J].
Coelho, J ;
Woodford, N ;
Turton, J ;
Livermore, DM .
JOURNAL OF HOSPITAL INFECTION, 2004, 58 (03) :167-169
[6]   Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents [J].
Coelho, J ;
Woodford, N ;
Afzal-Shah, M ;
Livermore, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :756-758
[7]  
FLAHERTY JP, 2004, HOSP EPIDEMIOLOGY IN, P575
[8]   The epidemiology and control of Acinetobacter baumannii in health care facilities [J].
Fournier, PE ;
Richet, H .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (05) :692-699
[9]   Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. [J].
Grundmann, HJ ;
Towner, KJ ;
Dijkshoorn, L ;
GernerSmidt, P ;
Maher, M ;
Seifert, H ;
Vaneechoutte, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3071-3077
[10]   Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii [J].
Héritier, C ;
Poirel, L ;
Lambert, T ;
Nordmann, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) :3198-3202